A METHOD FOR ESTIMATING THE POTENCY OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS IN MAN

被引：18

作者：

WELLSTEIN, A

ESSIG, J

BELZ, GG

机构：

[1] ALWINENSTR 16,D-6200 WIESBADEN,FED REP GER

[2] INST KARDIOVASKULARE THERAPIE,WIESBADEN,FED REP GER

[3] UNIV FRANKFURT,ZENTRUM PHARMAKOL,D-6000 FRANKFURT 1,FED REP GER

来源：

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1987年 / 24卷 / 03期

关键词：

D O I：

10.1111/j.1365-2125.1987.tb03188.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：397 / 399

页数：3

共 12 条

[1] SOME QUANTITATIVE USES OF DRUG ANTAGONISTS [J].

ARUNLAKSHANA, O ;

SCHILD, HO .

BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1959, 14 (01) :48-58

[2]

BELZ GG, 1986, MED KLIN, V81, P524

[3] HEMODYNAMIC-RESPONSES TO ANGIOTENSIN-I IN NORMAL VOLUNTEERS AND THE ANTAGONISM BY THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR CILAZAPRIL [J].

BELZ, GG ;

ESSIG, J ;

WELLSTEIN, A .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1987, 9 (02) :219-224

[4]

GADDUM JH, 1957, PHARMACOL REV, V9, P211

[5] THE DESIGN OF A NEW GROUP OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITORS [J].

HASSALL, CH ;

KROHN, A ;

MOODY, CJ ;

THOMAS, WA .

FEBS LETTERS, 1982, 147 (02) :175-179

[6] BIOLOGICAL PROPERTIES OF THE ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR CILAZAPRIL [J].

NATOFF, IL ;

NIXON, JS ;

FRANCIS, RJ ;

KLEVANS, LR ;

BREWSTER, M ;

BUDD, J ;

PATEL, AT ;

WENGER, J ;

WORTH, E .

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1985, 7 (03) :569-580

[7] ENZYMES OF THE RENIN-ANGIOTENSIN SYSTEM AND THEIR INHIBITORS [J].

ONDETTI, MA ;

CUSHMAN, DW .

ANNUAL REVIEW OF BIOCHEMISTRY, 1982, 51 :283-308

[8] MODIFICATION OF RECEPTOR THEORY [J].

STEPHENSON, RP .

BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1956, 11 (04) :379-393

[9]

STRITTMATTER SM, 1986, MOL PHARMACOL, V29, P142

[10]

VANDENBRINK FG, 1977, HDB EXPT PHARMAKOLOG, V47, P169

← 1 2 →